Heart Failure Clinical Trial

Implementation of a Protocol Utilizing Adaptive CRT in a Normal AV Conduction, CRT Non-Response Population at Generator Replacement

Summary

IMPROVE RESPONSE is a physician initiated research study. It is a prospective, non-randomized, multi-center, post-market, U.S. Cardiac Resynchronization Therapy (CRT) in heart failure (HF) observational study. The purpose of this clinical study is to test the hypothesis that market-released CRT devices, which contain the AdaptivCRT (aCRT) algorithm have an incremental benefit in improving CRT response in a chronic CRT non responder population with left bundle branch block (LBBB) and normal atrio-ventricular (AV) condition compared to CRT devices with traditional biventricular pacing delivery methods at generator replacement.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Normal AV conduction (SAV<220 ms or PAV<270 MS)
Left Bundle Branch Block (defined as > or = to 140 ms (male) or > or = 130 (female), QR or rS in leads V1 and V2, and Mid QRS notching or slurring in v 2 of leads V1, V2, V5, V6 and I and aVL.)
Patient and/or physician assessment or unchanged or worsened heart failure status at the time of recommended replacement time (RRT) for previous CRT device.
Sinus Rhythm at the time of enrollment

Exclusion Criteria:

Moderate to severe Aortic Stenosis
Moderate to severe Mitral Regurgitation
Patient age <18 years old
AF burden >15%
Severe pulmonary disease requiring supplemental oxygen use
ESRD
System Modification at RRT Generator Changeout
AdaptivCRT prior to enrollment
Expected patient longevity < 1 year
Persistant or chronic atrial fibriliation
Women who are pregnant or who plan to become pregnant during the clinical trial

Study is for people with:

Heart Failure

Estimated Enrollment:

1

Study ID:

NCT03305393

Recruitment Status:

Terminated

Sponsor:

Stern Cardiovascular Foundation, Inc.

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stern Cardiovascular Foundation
Germantown Tennessee, 38138, United States

How clear is this clinincal trial information?

Study is for people with:

Heart Failure

Estimated Enrollment:

1

Study ID:

NCT03305393

Recruitment Status:

Terminated

Sponsor:


Stern Cardiovascular Foundation, Inc.

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider